Paper
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
Published Dec 31, 2013 · M. Poljak, K. Seme, P. J. Maver
Vaccine
Q1 SJR score
80
Citations
11
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Literature Review
Highly CitedStudy Snapshot
HPV vaccination is not fully implemented in Central and Eastern European countries due to high vaccine costs and negative public perception, but screening practices show promising results.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
HPV testing in screening programs may be beneficial in countries with high cervical cancer rates, but current implementation is limited due to pricing, availability, and public awareness.
2013·67citations·S. Rogovskaya et al.·Vaccine
Vaccine
Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
Universal HPV vaccination with enhanced screening could significantly reduce the burden of cervical cancer in Central and Eastern Europe and Central Asia.
2013·98citations·F. Bray et al.·Vaccine
Vaccine
Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer
HPV16, 18, and 45 are key factors in cervical cancer, warranting special attention in HPV-based screening programs.
2012·846citations·P. Guan et al.·International Journal of Cancer
International Journal of Cancer
Tumor‐specific and gender‐specific pre‐vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: A study on 574 tissue specimens
The majority of anogenital warts and laryngeal papillomas can be prevented with a quadrivalent vaccine, with HPV-11 being more prevalent in males with anogenital warts.
2012·63citations·K. F. Komloš et al.·Journal of Medical Virology
Journal of Medical Virology
Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study.
Pre-vaccination prevalence of high-risk HPV types in Slovenian women was 12.9%, with HPV16 prevalence being 3.5% and HPV18 1.0%, and HPV16 prevalence increasing with severity.
2012·30citations·V. Učakar et al.·Vaccine
Vaccine
Worldwide burden of cervical cancer in 2008.
Cervical cancer remains a major public health problem, with 530,000 cases and 275,000 deaths in 2008, and new methods of prevention should be accessible and accessible for women in all countries through well-organized programs.
2011·1074citations·M. Arbyn et al.·Annals of oncology : official journal of the European Society for Medical Oncology
Annals of oncology : official journal of the European Society for Medical Oncology
Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
Hungarian adolescents' awareness of HPV is low, and well-designed HPV-focused educational programs are needed to increase their knowledge and acceptance of the vaccine, potentially reducing cervical cancer incidence.
2011·79citations·E. Marek et al.·Vaccine
Vaccine
Human Papillomavirus Genotype Distribution in Czech Women and Men with Diseases Etiologically Linked to HPV
The prevalence of vaccinal and related HPV types in patients with HPV-associated diseases in the Czech Republic is very high, suggesting that routine vaccination against HPV could greatly reduce the burden of HPV-associated diseases.
2011·32citations·R. Tachezy et al.·PLoS ONE
PLoS ONE
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
HPV16/18 is associated with 70-76% of invasive cervical cancers worldwide, with HPV16/18 prevalence increasing from 1990 to 2010 and multiple infections complicating estimates.
2011·1004citations·Ni Li et al.·International Journal of Cancer
International Journal of Cancer
Citations
HPV-Related Cancers in Bosnia and Herzegovina: A Comprehensive Review
Implementing a national HPV vaccination program and cervical cancer screening is essential to reduce HPV-related morbidity and mortality in Bosnia and Herzegovina.
2024·0citations·Anamarija Parić et al.·Acta Medica Academica
Acta Medica Academica
Relationship Between Population Density, Availability of Gynecological Services, and Cervical Cancer Incidence and Mortality Across Administrative Units in Serbia and Bosnia and Herzegovina During 2016–2020
Higher population density and gynecological service availability are associated with lower cervical cancer incidence and mortality rates in Serbia and Bosnia and Herzegovina.
2024·1citation·V. Vuković et al.·Medicina
Medicina
Prevalence and distribution of human papillomavirus genotypes in women with abnormal cervical cytology in Ethiopia: a systematic review and meta-analysis
The most prevalent HPV genotypes in Ethiopia are HPV-51, HPV-52, HPV-31, and HPV-33, suggesting a nonavalent vaccine type for cervical cancer prevention.
2024·1citation·Solomon Demis Kebede et al.·Frontiers in Oncology
Frontiers in Oncology
Analysis of the global burden of cervical cancer in young women aged 15–44 years old
The global burden of cervical cancer in young women aged 15-44 years is increasing, with population growth and age structure changes causing a growing demand for treatment and support services.
2024·3citations·Min Zhang et al.·The European Journal of Public Health
The European Journal of Public Health
Papanicolaou test in Brazil: analysis of the National Health Survey of 2013 and 2019
Despite high coverage of cervical cancer screening in Brazil, there is inequality in access, highlighting the need for organized screening programs to identify and capture vulnerable women.
2023·7citations·G. A. Silva et al.·Revista de Saúde Pública
Revista de Saúde Pública
Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries
European countries need better categorization of vulnerable subgroups to effectively increase cervical cancer screening coverage among them.
2023·5citations·M. Mallafré-Larrosa et al.·The European Journal of Public Health
The European Journal of Public Health